Akèy › Maladi Crohn › Ohio › Cleveland
Etid klinik pou Maladi Crohn nan Cleveland, OH
19 etid pou Maladi Crohn ap chèche patisipan nan sit nan ak bò kote Cleveland (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
Ap rekriteFaz 3
- Great Lakes Gastroenterology Research, LLC ( Site 5016), Mentor · 22 mi lwen
Investigating the Effect of the Non-nutritive Sweetener Sucralose in Inflammatory Bowel Disease
Ap rekriteVolontè an sante akeyi
- University Hospitals Cleveland Medical Center, Cleveland
- UH Minoff Health Center, Chagrin Falls · 17 mi lwen
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
Ap rekriteFaz 4
- Great Lakes Gastroenterology Research, LLC, Mentor · 22 mi lwen
Non-nutritive Sweeteners in Inflammatory Bowel Disease
Ap rekriteVolontè an sante akeyi
- University Hospitals Cleveland Medical Center, Cleveland
- UH Minoff Health Center, Chagrin Falls · 17 mi lwen
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
Ap rekriteFaz 2
- Great Lakes Gastroenterology Research, LLC, Mentor · 22 mi lwen
A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
Ap rekriteFaz 3
- Great Lakes Gastroenterology Research, LLC, Mentor · 22 mi lwen
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Ap rekriteFaz 3
- University Hospitals Cleveland Medical Center-Site Number: 8400073, Cleveland
A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease
Ap rekriteFaz 3
- Cleveland Clinic - Cleveland /ID# 256453, Cleveland
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
Ap rekriteFaz 4
- Great Lakes Gastroenterology Research, LLC, Mentor · 22 mi lwen
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
Ap rekriteFaz 3
- Great Lakes Gastroenterology Research, LLC, Mentor · 22 mi lwen
Ultrasound-Guided Versus Standard Margin Selection in Ileocecal Resection of Terminal Ileal CD
Ap rekrite
- Cleveland Clinic, Cleveland
Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn's Disease
Ap rekriteFaz 3
- UH Cleveland Medical Center /ID# 262188, Cleveland
A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
Ap rekriteFaz 3
- University Children's Clinic, Cleveland
- Cleveland Clinic, Cleveland
Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease
Ap rekriteFaz 4
- UH/Rainbow Babies and Children's Hospital, Cleveland
A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
Ap rekriteFaz 3
- University Hospitals Cleveland Medical Center - 11100 Euclid Ave, Cleveland
Precise Infliximab Exposure and Pharmacodynamic Control
Ap rekriteFaz 2/3
- Cleveland Clinic Children's Hospital, Cleveland
A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)
Ap rekriteFaz 3
- University Hospitals Cleveland Medical Center, Cleveland
Treatment of Moderate to Severe Refractory Crohn's Disease
Ap rekriteFaz 1/2
- Cleveland Clinic, Cleveland
Development of a Novel Endoscopic Index and Patient-reported Outcome Measure for Clinical Trials in Participants With Permanent Ileostomy
Ap rekriteEtid obsèvasyon
- Cleveland Clinic Foundation, Cleveland
Etid Maladi Crohn nan lòt vil
- New York City, NY35 etid
- Boston, MA19 etid
- Miami, FL19 etid
- St. Louis, MO19 etid
- Tyler, TX17 etid
- Houston, TX17 etid
- Orlando, FL17 etid
- Atlanta, GA17 etid
- San Antonio, TX15 etid
- San Diego, CA15 etid
- Los Angeles, CA15 etid
- Colorado Springs, CO13 etid
Lòt etid nan Cleveland
- Kansè Poumon ki pa ti selil43 etid
- Kansè (tout kalite)36 etid
- Kansè nan tete35 etid
- Kansè pwostat34 etid
- Ensifizyans kadyak33 etid
- Kansè ovè30 etid
- Kansè Metastatik30 etid
- Kansè poumon26 etid
- Kansè kolorektal24 etid
- Maladi kadyovaskilè22 etid
- Kansè Endomèt20 etid
- Leksemi mieloïd egi20 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.